Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Chimenti

Showing results (191-200 of 217) with videos related to

Pageof 22
Sort By:
Dermatology (Basel, Switzerland)|August 8, 2008
Recommendations for the long-term treatment of psoriasis with infliximab: a dermatology expert group consensusKristian Reich, Christopher Griffiths, Jonathan Barker, et al.
Archives of Dermatology|January 21, 2003
Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive casesChrista Prins, Francisco A Kerdel, R Steven Padilla, et al.
Dermatologic Therapy|December 8, 2017
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG surveyMaria C Potenza, Ketty Peris, Enzo Berardesca, et al.
Advances in Therapy|April 23, 2017
The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic PatientsDelia Colombo, Giuseppe Banfi, Nicoletta Cassano, et al.
Nature Medicine|August 18, 2009
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasisRoberta Caruso, Elisabetta Botti, Massimiliano Sarra, et al.
The Journal of Investigative Dermatology|November 25, 2011
Allele-specific cytokine responses at the HLA-C locus: implications for psoriasisChristian Hundhausen, Anna Bertoni, Rose K Mak, et al.
Oncotarget|January 21, 2017
The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasisAnastasia De Luca, Debora Carpanese, Maria Cristina Rapanotti, et al.
The Journal of Clinical Investigation|April 29, 2010
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasiasFrancesca Moretti, Barbara Marinari, Nadia Lo Iacono, et al.
Journal of the American Academy of Dermatology|June 20, 2015
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)Kim Papp, Kristian Reich, Craig L Leonardi, et al.
The Journal of Dermatological Treatment|April 30, 2013
Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patientsRosita Saraceno, Germana Camplone, Magda D'Agostino, et al.
Pageof 22

Showing results (191-200 of 217) with videos related to

Sort By:
Pageof 22
Dermatology (Basel, Switzerland)|August 8, 2008
Recommendations for the long-term treatment of psoriasis with infliximab: a dermatology expert group consensusKristian Reich, Christopher Griffiths, Jonathan Barker, et al.
Archives of Dermatology|January 21, 2003
Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive casesChrista Prins, Francisco A Kerdel, R Steven Padilla, et al.
Dermatologic Therapy|December 8, 2017
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG surveyMaria C Potenza, Ketty Peris, Enzo Berardesca, et al.
Advances in Therapy|April 23, 2017
The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic PatientsDelia Colombo, Giuseppe Banfi, Nicoletta Cassano, et al.
Nature Medicine|August 18, 2009
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasisRoberta Caruso, Elisabetta Botti, Massimiliano Sarra, et al.
The Journal of Investigative Dermatology|November 25, 2011
Allele-specific cytokine responses at the HLA-C locus: implications for psoriasisChristian Hundhausen, Anna Bertoni, Rose K Mak, et al.
Oncotarget|January 21, 2017
The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasisAnastasia De Luca, Debora Carpanese, Maria Cristina Rapanotti, et al.
The Journal of Clinical Investigation|April 29, 2010
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasiasFrancesca Moretti, Barbara Marinari, Nadia Lo Iacono, et al.
Journal of the American Academy of Dermatology|June 20, 2015
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)Kim Papp, Kristian Reich, Craig L Leonardi, et al.
The Journal of Dermatological Treatment|April 30, 2013
Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patientsRosita Saraceno, Germana Camplone, Magda D'Agostino, et al.
Pageof 22